Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Read
Cidara Therapeutics Announces Agreement With Janssen To Develop And Commercialize AVCs For The Prevention And Treatment Of Influenza
Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Article By:
TalkMarkets Newswire
Thursday, April 1, 2021 8:59 AM EDT
Cidara is developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections.
In this article: CDTX
3 Of The Best & Worst Performing Drug Stocks Of Q1
Article By:
Arpita Dutt
Thursday, April 6, 2017 11:37 AM EDT
Pharma and biotech stocks have been showing signs of recovery this year. The sector started the year on a strong note with the Nasdaq Biotechnology Index and the NYSE ARCA Pharmaceutical Index gaining 10.7% and 5.7%, in the first quarter of 2017.
Party City IPO Debuts On NYSE
Article By:
Zacks Investment Research
Thursday, April 16, 2015 7:26 AM EDT
Party City Holdco Inc.began trading on the New York Stock Exchange today, Apr 16. The initial public offering of 21.9 million shares are priced at $17.00 per share, at par with lower end of the expected range of $17 to $19 per share.